NCT07325734 The Effectiveness of Guided Written Exposure Therapy for Complex PTSD in Adolescents
| NCT ID | NCT07325734 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University |
| Condition | CPTSD, Compelx Post-traumatic Stress Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2025-10-10 |
| Primary Completion | 2026-11-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2025-10-10 with a primary completion date of 2026-11-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to examine the effectiveness of group Guided Written Exposure Therapy for Complex Post-Traumatic Stress Disorder (GWE-C) among Chinese adolescents through a randomized controlled trial. A total of 120 participants will be recruited, with 60 randomized to the GWE-C group and 60 randomized to the supportive therapy (ST) group. The GWE-C intervention will consist of 7 to 10 group sessions. The primary outcome, assessed by the International Trauma Questionnaire (ITQ), will be measured at baseline, post-treatment, 1-month follow-up, and 3-month follow-up.
Eligibility Criteria
Inclusion Criteria: 1. Aged between 10 and 18 years; 2. Meet the diagnostic or subclinical criteria for Complex PTSD (C-PTSD), defined as missing at most one symptom from either the PTSD or DSO clusters; 3. Possess sufficient literacy and language skills to complete writing-based tasks; 4. Be able to understand the study procedures and complete the required assessments; 5. Provide written informed consent, with consent also obtained from their legal guardians. Exclusion Criteria: 1. Presence of a severe psychiatric disorder or neurodevelopmental disorder, such as schizophrenia, bipolar I disorder, autism spectrum disorder, intellectual disability, or other severe psychiatric conditions that would interfere with study participation; 2. Presence of a severe physical illness that would impair the ability to engage in the intervention; 3. Assessed as being at high suicidal risk (e.g., current suicidal ideation with intent or plan, recent suicide attempt within the past 12 months, or severe self-harm behaviors); 4. Ongoing exposure to traumatic events; 5. Currently receiving other trauma-focused psychological treatments.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07325734 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying CPTSD, Compelx Post-traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07325734 currently recruiting?
Yes, NCT07325734 is actively recruiting participants. Contact the research team at yinyin.zang@pku.edu.cn for enrollment information.
Where is the NCT07325734 trial being conducted?
This trial is being conducted at Fuyang, China, Beijing, China.
Who is sponsoring the NCT07325734 clinical trial?
NCT07325734 is sponsored by Peking University. The trial plans to enroll 130 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.